Fundz

Lentechs Announces Successful $6 Million Fundraise To Further Key Development Objectives

PRIVATEOct 24, 2023

Amount Raised

$6 Million

Round Type

Funding Round

ColumbusHealthcare

Investors

Rev1 VenturesBluestem CapitalOhio Innovation FundJobs Ohio Growth Capital FundVision Vestments LLC

Description

Lentechs, a clinical-stage ophthalmic medical device company developing a new generation of soft, suspended contact lens, designed to transform the treatment paradigm for presbyopia, announced the closing of a successful fundraise to further key development objectives for its investigational contact lens for patients with presbyopia. The round was led by Vision Vestments LLC, with additional significant investments from JobsOhio Growth Capital Fund, Ohio Innovation Fund, Bluestem Capital, and Rev1 Ventures.

Quick answer

Lentechs raised $6 Million in a Funding Round round, dated October 24, 2023. Investors: Rev1 Ventures, Bluestem Capital, Ohio Innovation Fund, Jobs Ohio Growth Capital Fund and Vision Vestments LLC. Lentechs is based in Columbus, Ohio, United States.

How much did Lentechs raise?
Lentechs raised $6 Million in a Funding Round round on October 24, 2023.
Who invested in Lentechs?
Rev1 Ventures, Bluestem Capital, Ohio Innovation Fund, Jobs Ohio Growth Capital Fund and Vision Vestments LLC are named as investors in this round.
What does Lentechs do?
LENTECHS, LLC is a privately-held, clinical stage ophthalmic medical device company focused on developing a new generation of soft, suspended contact lens, with a platform of offerings to span the patient lifecycle.
Where is Lentechs based and how big is it?
Lentechs is based in Columbus, Ohio, United States.
Who are the decision-makers at Lentechs?
Fundz holds 1 contact at Lentechs, including the Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as Lentechs that raised within 45 days of this round, from Fundz verified event records.

  • Phio Pharmaceuticals raised $533K (Seed) on December 8, 2023.
  • VILLYA raised $250K on December 8, 2023.
  • Os Therapies raised $700K on December 8, 2023.
  • Toetal Solutions raised $150K (Seed) on December 8, 2023.
  • Spesana Inc. raised $500K (Seed) on December 7, 2023.
  • Diasome Pharmaceuticals raised an undisclosed amount (Series C) on December 7, 2023.

Who to call at Lentechs, and when

A new round usually means Lentechs is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Lentechs raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lentechs, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lentechs. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Lentechs

Location

Columbus, Ohio, United States

About

LENTECHS, LLC is a privately-held, clinical stage ophthalmic medical device company focused on developing a new generation of soft, suspended contact lens, with a platform of offerings to span the patient lifecycle. Its flagship contact lens platform, APIOC™ has a patented design for suspension of the lens from behind the upper eyelid and is designed based on the anatomy of the eye. Collaboratively founded with its optometrist inventors Melissa Bailey, OD, PhD, and Joe Barr, OD, MS, FAAO, LENTECHS has successfully developed its core technology licensed from The Ohio State University. APIOC for Presbyopia and APIOC for Presbyopia with Astigmatism will launch in early-2022. This new generation of soft, suspended contact lens is designed to help Presbyopes achieve glasses-like vision with the freedom of a contact lens.™ LENTECHS was incorporated in 2017, is headquartered in Columbus, Ohio, and is funded by a network of investors committed to revolutionary innovation in contact lenses.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Lentechs raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsBrad B., Executive Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Lentechs's next move

See what Strategic adds

Lentechs raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.